BioIntelliSense BioCloud

by BioIntelliSense, Inc.  · Based in United States → — Early Detection Made Simple™: Continuous Health Monitoring and Clinical Intelligence
Geriatrics Hospital Medicine Internal Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

BioIntelliSense BioCloud is a cloud-based data analytics and clinical intelligence engine designed to power continuous, medical-grade patient monitoring. The platform serves as the central data ingestion and processing hub for the BioIntelliSense ecosystem, which includes the BioButton and BioSticker wearable sensors, BioHub gateways, and the BioMobile application.

The system is designed for healthcare providers, hospital systems, and virtual care teams operating across inpatient general care units, remote patient monitoring (RPM) programs, and hospital-at-home settings. It supports clinicians in proactively managing patient populations by automating the collection of high-frequency physiological data.

In a typical clinical workflow, patients wear a continuous monitoring sensor that wirelessly transmits up to 1,440 sets of vital sign measurements per day via Bluetooth to a local gateway. The gateway securely forwards this data to the BioCloud platform. BioCloud utilizes algorithmic and rules-based analytics to detect adverse trends and patterns in vital signs, such as resting heart rate, resting respiratory rate, skin temperature, and activity levels. These processed insights and automated notifications are then displayed to clinicians via the BioDashboard interface or integrated directly into the electronic health record (EHR) system, enabling timely clinical interventions before symptomatic deterioration occurs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Continuous multi-parameter vital sign monitoring (heart rate, respiratory rate, skin temperature)
  • Physiological biometrics tracking (activity levels, sleep, body position, gait analysis)
  • FDA-cleared BioSticker and BioButton wearable biosensors
  • BioCloud data analytics and algorithmic-based alerting
  • BioDashboard clinical intelligence system for exception management
  • EMR system integration and data exchange capabilities
  • Flexible gateway options (BioHub Wi-Fi, BioHub Cellular)
  • BioMobile app for patient engagement and data transfer
  • Automated vital sign collection to reduce manual tasks
  • Early detection of clinical deterioration and adverse trends

Use Cases

  • In-facility patient monitoring in non-critical care units
  • At-home remote patient monitoring (RPM)
  • Hospital virtual care programs and hospital-at-home initiatives
  • Post-discharge complex care management
  • Chronic disease management (e.g., CHF, COPD, Diabetes)
  • COVID-19 screening and infectious disease monitoring

What Physicians Need to Know

Key Capabilities
BioCloud is a secure, medical-grade data and analytics platform that works with BioIntelliSense's FDA-cleared wearable devices (BioSticker, BioButton) to provide continuous health monitoring. It collects vital signs such as heart rate, respiratory rate, skin temperature, activity, body position, and sleep data, up to 1,440 measurements per patient per day. The platform uses AI to detect patterns in vital signs, inform proactive clinical interventions, and generate customizable alerts and reports. It supports remote patient monitoring (RPM) and provides clinicians with a BioDashboard interface for near real-time insights and exception management.
Clinical Utility
BioCloud aims to improve patient outcomes through early detection of clinical deterioration, with studies showing detection of 73% of deterioration events within 24 hours and an average of 14.8 hours prior to symptomatic changes. It supports reduced hospitalizations and readmissions, and can shorten the average length of stay for medical-surgical patients by approximately 7.7 to 9 hours. The system enhances clinical workflows by automating vital sign collection, reducing manual charting time by 50%, and providing data-driven insights for proactive decision-making and resource allocation. It also helps reduce alert fatigue with low notification rates (less than 1 per patient per day).
Integration Options
The BioCloud platform is designed for seamless integration into existing clinical workflows and offers API integration for EHR/EMR systems, including Epic. It also integrates with over 20 best-in-class RPM applications and telehealth solutions, and can connect with third-party systems for data exchange. BioIntelliSense utilizes BioHubu2122 gateways (cellular 5G-enabled and Wi-Fi) and BioMobileu2122 downloadable applications (iOS and Android) for secure data transmission from wearable devices to the BioCloud.
Compliance Status
BioCloud is a medical-grade data and analytics platform, and its associated BioButton and BioSticker devices are FDA-cleared. The platform is HIPAA-compliant and aligns its architecture with requirements of the National Institute of Standards and Technology, ISO 27000, and SOC 2, utilizing AWS for secure cloud-based systems.
Pricing Model
The specific pricing model (e.g., subscription, per-use) is not explicitly detailed on the public solution page. However, the system is noted to offer economies of scale for hospitals, aiming to make continuous care more affordable and accessible, and can save significant operational costs.
User Experience
The system emphasizes an effortless user experience for patients with comfortable, discreet wearable devices (BioButton, BioSticker) that passively capture data without interrupting sleep. For clinicians, the BioDashboard provides an intuitive, centralized view of high-frequency patient trending data with algorithmic-based alerting, designed for efficient exception management and high clinician engagement.
Support Quality
While specific details on support quality are not extensively outlined on the public solution page, BioIntelliSense offers program implementation and deployment services, including device provisioning, gateway installation, and clinical workflow integration, along with device support, documentation, and training. Partnerships with virtual care providers like Hicuity Health also offer fully managed, end-to-end continuous patient monitoring services.
Implementation Complexity
The system is designed for scalability and quick onboarding, leveraging cloud infrastructure (AWS). While it offers robust API integration for EHR/EMR, suggesting some IT involvement, the company also provides program implementation and deployment services to streamline the process, including clinical workflow integration. Implementations have been completed in accelerated cycles, demonstrating efficient deployment.
Evidence Base
The BioCloud platform and its associated devices are FDA-cleared. A peer-reviewed retrospective observational study published in the Journal of Clinical Medicine demonstrated that continuous wireless vital sign monitoring via the BioButton system enabled early detection of clinical deterioration (73% of events within 24 hours), reduced patient length of stay, and showed low alert notification rates. The devices provide continuous monitoring with high clinical accuracy.
Physician Tip

Leverage BioCloud's continuous monitoring and AI-driven alerts for proactive patient management, especially in high-risk or remote care settings. Integrate the BioDashboard into your daily workflow for a centralized, exception-based view of patient trends, reducing the need for frequent manual vital sign checks and minimizing alert fatigue. Utilize the data for informed decision-making, earlier interventions, and to support initiatives for reducing length of stay and readmissions. Consider its utility for both in-hospital and hospital-at-home programs to optimize resource allocation and enhance patient experience.

BioIntelliSense BioCloud offers robust integration capabilities, including API integration with major EHR/EMR systems like Epic, and compatibility with numerous RPM and telehealth solutions. This allows for a unified patient data view and streamlined clinical workflows. The use of BioHub gateways (Wi-Fi, cellular, 5G) and BioMobile apps ensures flexible and secure data transmission from wearable devices to the cloud platform, facilitating comprehensive data flow within your existing healthcare IT ecosystem.

Details

Category Triage & ER/ICU AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
  • Custom pricing for healthcare providers and organizations; not available for direct consumer purchase
DeploymentCloud-based platform with interoperable solutions for EMR integration.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The BioSticker and BioButton wearable devices, as well as the BioButton Multi-Patient wearable and BioDashboard system, have received FDA clearance for continuous vital sign monitoring and clinical intelligence.
Integrations
EHR Not specified
Specialties Geriatrics, Hospital Medicine, Internal Medicine

What the Web Says

BioIntelliSense BioCloud is a platform that works in conjunction with wearable BioButton devices to provide continuous patient monitoring and clinical intelligence. It uses AI to detect patterns in vital signs, aiming for early detection of patient deterioration and improved patient outcomes. The system is designed to reduce the burden on nursing staff by automating vital sign collection and offering a centralized monitoring interface.

Overall: Positive

Strengths

  • Early detection of clinical deterioration events (up to 73% detected early).
  • Reduces time nurses spend on manual vital sign collection (up to 50% reduction).
  • Shorter average length of stay for patients (e.g., 9 hours shorter for medical-surgical patients).
  • Reduces alarm fatigue with fewer notifications compared to traditional systems.
  • Enables continuous, near real-time monitoring of vital signs.
  • Supports both in-hospital and home care settings.

Limitations

  • Requires proper training for doctors, nurses, and IT staff.
  • Potential threats to confidentiality and privacy of patient data.
  • The BioButton device is not intended for real-time or critical care monitoring and data should not be used as the sole basis for diagnosis or therapy.
  • Some clinical deterioration events may not be preceded by a BioIntelliSense notification (e.g., those related to low blood oxygenation or hypotension).
  • Limited information available from independent tech reviewers, Reddit, G2, or Capterra.
  • Initial versions of the BioDashboard interface faced scalability limitations with SQL Server.

Based on reviews from: AWS (Amazon Web Services), BioIntelliSense Evidence Page, MongoDB Case Study, Journal of Clinical Medicine (via PMC and BioIntelliSense press release), DOH Health Technology Review, FDA approval announcements, TechTarget, HIT Consultant, Fierce Biotech, Scouting Report-BioIntelliSense, Zippia, YouTube (Renown Health), Ardent Health Services

Last updated: 2026-07-21

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate BioIntelliSense BioCloud

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

BioIntelliSense Press Release
BioIntelliSense Announces FDA Clearance of the BioButtonu00ae Multi-Patient Wearable and BioDashboardu2122
BioIntelliSense received FDA clearance for its rechargeable BioButton Multi-Patient wearable and BioDashboard system, enabling scalable and cost-effective continuous patient monitoring in hospitals and at home.
2024-10
Pharma Technology
FDA approves BioIntelliSense's BioButton wearable for patient monitoring
The FDA has approved BioIntelliSense's BioButton Multi-Patient wearable and BioDashboard system, which facilitates continuous vital sign monitoring and aims to improve patient safety and workflow efficiency by reducing manual tasks.
2024-10
BioIntelliSense Press Release
BioIntelliSense Announces Observational Study in Journal of Clinical Medicine
BioIntelliSense announced the publication of a peer-reviewed study in the Journal of Clinical Medicine, demonstrating that continuous wireless vital sign monitoring with the BioButton system and BioCloud analytics can detect clinical deterioration early and reduce hospital stays.
2025-11
Journal of Clinical Medicine (PMC)
A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients
This retrospective observational study found that the BioIntelliSense BioButton system, transmitting data to the BioCloud, enabled early detection of clinical deterioration and showed a decreasing trend in hospital length of stay.
2024-08
Business Wire
BioIntelliSense Partners with Hicuity Health to Offer Scalable End-to-End Continuous Patient Monitoring for U.S. Health Systems
BioIntelliSense partnered with Hicuity Health to provide scalable continuous patient monitoring solutions, integrating the BioButton wearable and BioDashboard with Hicuity Health's virtual monitoring services to address staffing challenges and improve patient outcomes.
2025-02
Amazon Web Services (AWS)
Early Detection of 73% of Clinical Deterioration Events Using AWS with BioIntelliSense
BioIntelliSense utilizes AWS to power its BioCloud platform, enabling early detection of clinical deterioration events and demonstrating a 73% early detection rate and a 9-hour reduction in average hospital stay.
unknown
BioIntelliSense Press Release
BioIntelliSense Announces Completion of Houston Methodist Inpatient Expansion of the BioButton
Houston Methodist completed the inpatient expansion of BioIntelliSense's BioButton continuous patient monitoring solution across all non-ICU beds, utilizing the BioCloud for data analytics to improve patient safety and workflow efficiencies.
2024-04
UC Davis Health
UC Davis Health and BioIntelliSense Form Strategic Collaboration to Advance Continuous Remote Care Models for In-Hospital to Home Monitoring
UC Davis Health and BioIntelliSense announced a strategic collaboration to advance remote patient monitoring using BioIntelliSense's wearable technology and algorithmic-based BioCloud data analytics across various care settings.
2022-05

Videos

Product demos, reviews, and walkthroughs for BioIntelliSense BioCloud.

Loading videos...

View all on YouTube

Frequently Asked Questions

BioCloud is a Data-as-a-Service (DaaS) platform that seamlessly captures minute-to-minute vital signs and physiological biometrics from FDA-cleared wearable devices like the BioButton and BioSticker. This data is then transmitted to the BioCloud for AI-driven analytics, providing clinicians with high-resolution patient trending and actionable insights via the BioDashboard interface to enable proactive clinical interventions.
BioIntelliSense adheres to strict privacy and security standards, including encrypting data at rest and in transit within the BioCloud, and has partnered with ClearDATA for enhanced security and compliance with HITRUST certification. BioIntelliSense's platform is built to adhere to rigorous security and compliance standards, and they offer a comprehensive Business Associate Agreement (BAA) to healthcare organization customers.
BioIntelliSense primarily operates on a per-patient per-month subscription model, which includes the wearable device, data transmission, and access to their BioViz analytics platform. Specific pricing tiers can vary significantly based on volume commitments, the duration of monitoring, and the complexity of integration required, with health systems often engaging in custom enterprise agreements.
While BioIntelliSense excels in continuous, multi-parameter data collection, other notable RPM alternatives include Philips Capsule/IntelliVue XDS for advanced hospital-grade analytics, Current Health for bundled services and nurse-led care, and Vivify Health for comprehensive remote care solutions with extensive device integration. Each offers distinct strengths in areas like advanced analytics, integrated services, or customizability for large health systems.
While BioCloud offers robust data acquisition, its analytics suite might require integration with broader EHR or AI platforms for deep predictive modeling. Additionally, while the system aims to reduce alert fatigue, initial studies noted that centralized nurse monitoring stations were sometimes only staffed during day shifts, which could impact response times outside those hours.
BioCloud utilizes AI-driven analytics to detect patterns in patients' vital signs and identify adverse trends, enabling proactive clinical interventions and earlier detection of deterioration events. Studies have shown that the system can detect 73% of clinical deterioration events early, with low notification rates (less than 1 per patient per day) to reduce alert fatigue.
Yes, the BioButton device, BioCloud platform, and BioDashboard interface received FDA clearance for multi-patient use in October 2024. This clearance provides economies of scale for hospitals, allowing one clinician to monitor hundreds of patients simultaneously and supporting scalable continuous care models for improved patient safety and workflow efficiencies.

Related Tools

KATE AI
Mednition
Clinical Decision Support & Reference
KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It has supported over 5,000,000 patient visits, helping emergency teams deliver safer, faster, and more informed care.
Fee-based, not publicly disclosed.
Sepsis Watch
Duke Health
Clinical Decision Support & Reference
Sepsis Watch is a deep learning alert system developed by Duke Health to identify and manage sepsis in real-time within ED and ICU settings. It has been associated with a significant reduction in sepsis deaths and improved compliance with treatment protocols.
CalmWave, Inc.
CalmWave, Inc.
Practice Analytics & BI
CalmWave is an AI-powered hospital operations platform designed to combat clinical alarm fatigue and improve patient safety and staff retention. It integrates real-time data from bedside monitors, other devices, alarms, and EHRs to provide actionable insights and reduce non-actionable alarms.
Bayesian Health Sepsis Flagging Device
Bayesian Health, Inc.
Clinical Decision Support & Reference
Bayesian Health's Sepsis Flagging Device is an AI clinical decision support system that monitors EHR data to provide early warnings for sepsis. It continuously monitors patient data across vitals, lab results, and clinical notes, identifying patterns that may indicate worsening conditions. The system puts out a flag, such as “sepsis risk high,” within the health record to help clinicians detect sepsis early.
Subscription-based platform
Vascular Assist Occlusion Triage (VAOT)
GuideAI Health
Clinical Decision Support & Reference
Vascular Assist Occlusion Triage (VAOT) is an AI tool by GuideAI Health designed to assist radiologists in the rapid identification of vascular occlusions from medical images.
Savience Digital Triage
Savience Ltd
Patient Intake & Forms
Savience Digital Triage is a patient-centered, data-driven intake solution that optimizes every step of the triage journey, from arrival to clinical assessment, by allowing patients to self-stream via kiosks or mobile devices and feeding symptom and urgency questions directly into clinical workflows.

See all Triage & ER/ICU AI tools →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.